You are here:
Hydroxychloroquine and Chloroquine: psychiatric disorders
2020.11.27
Active substance: hydroxychloroquine, chloroquine
EMA’s safety committee (PRAC) has recommended updating the product information for all chloroquine or hydroxychloroquine-containing medicines following a review of all available data that confirmed a link between the use of these medicines and the risk of psychiatric disorders and suicidal behaviour.
For more details please click on the following link to the homepage of the European Medicines Agency (EMA):